60
Participants
Start Date
October 1, 2014
Primary Completion Date
October 31, 2015
Study Completion Date
October 31, 2015
Sorafenib 400mg twice daily + intravenous infusion ofVit K1
Sorafenib 400mg twice daily + intravenous infusion ofVit K1 50 mg/day with daily increase of dose by 50 mg for 6 days, followed by oral Vitamin K1 20mg twice daily for 3month
Sorafenib 400 mg twice daily + Intravenousinfusion of placebo
Sorafenib 400 mg twice daily + Intravenousinfusion ofplacebo daily for 6 days, followed by oral placebo twice daily x 3month
Institute of Liver & Biliary Sciences, New Delhi
Institute of Liver and Biliary Sciences, India
OTHER